AbbVie Inc. (ABBV)

Every figure this model derived for ABBV, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,297,000,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 6,597,000,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 33,669,000,000 AssetsCurrent 2026-06-30
current liabilities 41,642,000,000 LiabilitiesCurrent 2026-06-30
equity -5,935,000,000 StockholdersEquity 2026-06-30
interest expense 2,916,000,000 InterestExpense 2026-06-30
ocf 19,507,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 64,386,000,000 Revenues 2026-06-30
sbc 976,000,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ABBV on one particular measure came for.

RatioValue
cash operating margin28.92
current ratio0.81
current ratio reported0.81
dilution pct0.0
ebit cagr-2.02
ev ebit30.34
ev owner earnings29.7
ev sales7.95
fcf margin28.28
growth cv1.49
interest cover5.79
net debt ebitda3.28
operating margin26.2
owner earnings margin26.77
revenue growth10.39
revenue growth per share10.39
roic25.62
rule of 4036.59
sbc pct revenue1.52

What to be careful about

What this model itself distrusts about ABBV's figures. Written by the derivation as it ran, not added afterwards.